Primary record
N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate
- 库存
- 5,252 克
- 纯度
- 99.4 %
- CAS
- 558447-26-0
化合物标识与属性
- CAS
- 558447-26-0
- PubChem CID
- 11256587
- SMILES
- C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3
- Canonical SMILES
- NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21
名称与同义词
- Mavorixafor
- AMD-070
- 558447-26-0
- mavorixaforum
- XOLREMDI
- AMD070
- Mavorixafor [USAN]
- AMD 070
- AMD11070
- Xolremdi (TN)
- 0G9LGB5O2W
- Mavorixafor (USAN)
- UNII-0G9LGB5O2W
- (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
- Cxcr4 inhibitor x4p-001
- X4p001
- AMD-11070
- AMD-070 hydrochloride
- AMD-070; Mavorixafor
- RefChem:155995
- MAVORIXAFOR [INN]
- MFCD11977316
- D0O2XQ
- CHEMBL518924
- A1D8L
- X4P-001
- MAVORIXAFOR [WHO-DD]
- AMD 11070
- GTPL8580
- orb1296155
- SCHEMBL2511950
- C21H27N5
- SCHEMBL29379072
- SCHEMBL29701264
- X 4P-001
- CTK8C0587
- DTXSID60971247
- QCR-228
- CHEBI:138865
- GLXC-04447
- X4P-001-IO
- X4P-001-LD
- BCP07108
- compound 2 [PMID: 20297846]
- EX-A2661
- IXA44726
- AMD-070 (AMD11070)
- 8157AB
- ANW-64931
- BDBM50315305
- NSC775637
- RW3962
- WHO 10724
- ZINC33359232
- AMD-070 HCl 75%(w/w%)
- CS-0352
- CS-1257
- DB05501
- NSC-775637
- X4P 001
- CID11256587
- EBC-2562075
- NCGC00378947-01
- NCGC00378947-02
- NCGC00378947-03
- AJ-85915
- DA-50384
- HY-50101
- SY260541
- TC-153676
- NS00071960
- ST24036370
- J2.798.825C
- A11315
- C20266
- D11510
- F31237
- N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
- W-5505
- A857602
- S14-0353
- BRD-K42948882-305-01-1
- Q27074430
- N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
- N-(1H-benzoimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
- N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
- N1-(1H-BENZIMIDAZOL-2-YLMETHYL)-N1-((S)-5,6,7,8-TETRAHYDROQUINOLIN-8-YL)-BUTANE-1,4-DIAMINE
- (S)-N1-[(2-Benzimidazolyl)methyl]-N1-(5,6,7,8-tetrahydro-8-quinolyl)-1,4-butanediamine
- N-(1H-Benzimidazol-2-ylmethyl)-N-(8S)-5,6,7,8-tetrahydro-8-quinolinyl-1,4-butanediamine
- (8S)-N-(4-aminobutyl)-N-((1H-1,3-benzodiazol-2-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine
- (8S)-N-(4-aminobutyl)-N-[(1H-1,3-benzodiazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine
- (S)-N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine
- (S)-N1-((1H-Benzo(d)imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
- 1,4-BUTANEDIAMINE, N-(1H-BENZIMIDAZOL-2-YLMETHYL)-N-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-
- 558441-90-0
- 690656-53-2
- AMD11070; AMD-11070; AMD 11070;AMD 070; AMD070; X4P-001; X4P 001; X4P001; mavorixafor
- N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate
- N-(1H-benzimidazol-2-ylmethyl)-N-((8S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
- N-(1H-Benzoimidazole-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinoline-8alpha-yl)-1,4-butanediamine
- N~1~-[(1H-1,3-Benzimidazol-2-yl)methyl]-N~1~-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
- N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine